Risk of ulcerative colitis-associated colorectal cancer in China: A multi-center retrospective study

Digestive Diseases and Sciences

Volumn 57, Issue 2, 2012, Pages 503-507

  Gong, Wei ^a   Lv, Nonghua ^b   Wang, Bangmao ^c   Chen, Ye ^a   Huang, Yinglong ^d   Pan, Wenshen ^e   Jiang, Bo ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d INNER MONGOLIA MEDICAL COLLEGE   (China)

^e ZHEJIANG UNIVERSITY   (China)

Author keywords

Colorectal cancer; Risk; Ulcerative colitis

Indexed keywords

MESALAZINE;

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; CANCER RISK; CHINA; COLORECTAL CANCER; DATA BASE; DISEASE DURATION; DISEASE SEVERITY; DYSPLASIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TEACHING HOSPITAL; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; CHINA; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 84856740553     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1890-9     Document Type: Article

References (29)

1. P Munkholm 2003 Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease Aliment Pharmacol Ther 18 1 5 12950413 10.1046/j.1365-2036.18.s2.2.x (Pubitemid 37174709)
2. PL Lakatos L Lakatos 2008 Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies World J Gastroenterol 7 3937 3947 10.3748/wjg.14.3937
3. B Crohn H Rosenberg 1925 The sigmoidoscopic picture of chronic ulcerative colitis (non-specific) Am J Med Sci 170 220 228 10.1097/00000441-192508010- 00006
4. JA Eaden KR Abrams JF Mayberry 2001 The risk of colorectal cancer in ulcerative colitis: a meta-analysis Gut 48 526 535 11247898 10.1136/gut.48.4.526 1:STN:280:DC%2BD3M3hs1Orsw%3D%3D (Pubitemid 32234798)
5. JE Lennard-Jones BC Morson JK Ritchie, et al. 1983 Cancer surveillance in ulcerative colitis: experience over 15 years Lancet 2 149 152 6134993 10.1016/S0140-6736(83)90129-0 1:STN:280:DyaL3s3ktlKjtQ%3D%3D (Pubitemid 13067438)
6. J Eaden 2004 Review article: colorectal carcinoma and inflammatory bowel disease Aliment Pharmacol Ther 20 24 30 15352890 10.1111/j.1365-2036.2004.02046. x (Pubitemid 39319243)
7. A Ekbom C Helmick M Zack, et al. 1990 Ulcerative colitis and colorectal cancer. A population-based study N Engl J Med 323 1228 1233 2215606 10.1056/NEJM199011013231802 1:STN:280:DyaK3M%2FhsFamtg%3D%3D (Pubitemid 20366527)
8. P Karlen R Lofberg O Brostrom, et al. 1999 Increased risk of cancer in ulcerative colitis: a population-based cohort study Am J Gastroenterol 94 1047 1052 10201481 1:STN:280:DyaK1M3hsFKltg%3D%3D (Pubitemid 29173626)
9. Z Maratka J Nedbal J Kocianova, et al. 1985 Incidence of colorectal cancer in proctocolitis: a retrospective study of 959 cases over 40 years Gut 26 43 49 3965367 10.1136/gut.26.1.43 1:STN:280:DyaL2M%2FnslOntg%3D%3D (Pubitemid 15109201)
10. EV Loftus Jr 2006 Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis Gastroenterol Clin North Am 35 517 531 16952738 10.1016/j.gtc.2006.07.005 (Pubitemid 44307577)
11. L Lakatos G Mester Z Erdelyi, et al. 2006 Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study Inflamm Bowel Dis 12 205 211 16534422 10.1097/01.MIB.0000217770.21261.ce
12. BJ Kim SK Yang JS Kim, et al. 2009 Trends of ulcerative colitis-associated colorectal cancer in Korea: a KASID study J Gastroenterol Hepatol 24 667 671 19378391 10.1111/j.1440-1746.2008.05730.x
13. S Venkataraman V Mohan BS Ramakrishna, et al. 2005 Risk of colorectal cancer in ulcerative colitis in India J Gastroenterol Hepatol 20 705 709 15853982 10.1111/j.1440-1746.2005.03810.x (Pubitemid 40733363)
14. L Jiang B Xia J Li, et al. 2006 Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China Inflamm Bowel Dis 12 212 217 16534423 10.1097/01.MIB.0000201098.26450.ae
15. J Yun CT Xu BR Pan 2009 Epidemiology and gene markers of ulcerative colitis in the Chinese World J Gastroenterol 15 788 803 19230040 10.3748/wjg.15.788 1:CAS:528:DC%2BD1MXpsFCgtLw%3D
16. JE Lennard-Jones 1989 Classification of inflammatory bowel disease Scand J Gastroenterol 24 2 6 10.3109/00365528909091339 (Pubitemid 20015811)
17. S Kudo S Tamura T Nakajima, et al. 1996 Diagnosis of colorectal tumorous lesions by magnifying endoscopy Gastrointest Endosc 44 8 14 8836710 10.1016/S0016-5107(96)70222-5 1:STN:280:DyaK28vjtlOgsg%3D%3D (Pubitemid 26268652)
18. C Hendriksen S Kreiner V Binder 1985 Long-term prognosis in ulcerative colitis based on results from a regional patient group from the county of Copenhagen Gut 26 158 163 3967834 10.1136/gut.26.2.158 1:STN:280: DyaL2M7gt12isg%3D%3D (Pubitemid 15105142)
19. J Kewenter H Ahlman L Hulten 1978 Cancer risk in extensive ulcerative colitis Ann Surg 188 824 828 736660 10.1097/00000658-197812000-00018 1:STN:280:DyaE1M7gt1Gmtg%3D%3D
20. M Rutter B Saunders K Wilkinson, et al. 2004 Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis Gastroenterology 126 451 459 14762782 10.1053/j.gastro.2003.11.010 (Pubitemid 38182302)
21. RB Gupta N Harpaz S Itzkowitz, et al. 2007 Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study Gastroenterology 133 1099 1105 17919486 10.1053/j.gastro.2007.08. 001 quiz 1340-1341 (Pubitemid 47494461)
22. JB Brown G Lee E Managlia, et al. 2010 Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis Gastroenterology 138 595 605 19879273 10.1053/j.gastro.2009.10.038 1:CAS:528:DC%2BC3cXivVCnsrk%3D
23. JP Terdiman M Steinbuch WA Blumentals TA Ullman DT Rubin 2007 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease Inflamm Bowel Dis 13 4 367 371 17206695 10.1002/ibd.20074 (Pubitemid 46668239)
24. CN Bernstein JF Blanchard C Metge, et al. 2003 Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol 98 2784 2788 14687833 10.1111/j.1572-0241. 2003.08718.x 1:CAS:528:DC%2BD3sXpvVahsLg%3D (Pubitemid 38020124)
25. F Shanahan 2003 Review article: colitis-associated cancer-time for new strategies Aliment Pharmacol Ther 18 6 9 12950414 10.1046/j.1365-2036.18.s2.5.x (Pubitemid 37174710)
26. JA Eaden JF Mayberry British Society for Gastroenterology Association of Coloproctology for Great Britain, Ireland 2002 Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease Gut 51 V10 V12 12221032 10.1136/gut.51.suppl-5.v10
27. SH Itzkowitz DH Present Crohn's and Colitis Foundation of America Colon Cancer in IBD Study Group 2005 Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease Inflamm Bowel Dis 11 314 321 15735438 10.1097/01.MIB.0000160811.76729.d5 (Pubitemid 40439686)
28. EV Loftus Jr GC Harewood CG Loftus, et al. 2005 PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis Gut 54 91 96 15591511 10.1136/gut.2004.046615 (Pubitemid 40007225)
29. D Pinczowski A Ekbom J Baron, et al. 1994 Risk factors for colorectal cancer in patients with ulcerative colitis: a case control study Gastroenterology 107 117 120 7912678 1:STN:280:DyaK2c3ptFynsA%3D%3D (Pubitemid 24195353)